Skip to main content
Clinical Trials/CTRI/2024/06/068780
CTRI/2024/06/068780
Not Yet Recruiting
N/A

An Early Detection of Cancer and Prediction of Tissue of Origin with PredOmix OncoVeryx© to confirm Precision and/or Accuracy in Cancer and Non-Cancerous Population: A Prospective Trial of OncoVeryx© for Early Detection of Cancer and Prediction of Tissue of Origin - Nil

MS Clinfinite Solutions0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
MS Clinfinite Solutions
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
MS Clinfinite Solutions

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects who voluntarily participate in this study by signing their Informed Consent Form
  • (ICF) in the local language prior to any study\-mandated procedure.
  • 2\. Males or females aged \= 18 years at time of signing the ICF.
  • 3\. Group 1:
  • i. Subjects who are diagnosed with or suspected to have any cancer type.
  • ii. Subjects must be treatment naive \[i.e., should not have history of any chemotherapy, immunotherapy, radiotherapy etc.,].

Exclusion Criteria

  • 1\. Currently participating in another investigational study.
  • 2\. Female subjects who are pregnant
  • 3\. Subjects with either high\-grade dysplasia, autoimmune disease, or chronic kidney disease.
  • 4\. Subjects has a condition that, in the opinion of the investigator, would preclude participation in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials